EWM
ALXN
Evercore Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,655
| Closed | -$253K | – | 441 |
|
|
2021
Q1 | $253K | Sell |
1,655
-362
| -18% | -$55.3K | 0.01% | 392 |
|
|
2020
Q4 | $315K | Buy |
+2,017
| New | +$315K | 0.01% | 351 |
|
|
2018
Q1 | – | Sell |
-1,480
| Closed | -$177K | – | 859 |
|
|
2017
Q4 | $177K | Sell |
1,480
-229
| -13% | -$27.4K | 0.01% | 380 |
|
|
2017
Q3 | $240K | Buy |
1,709
+44
| +3% | +$6.18K | 0.01% | 338 |
|
|
2017
Q2 | $202K | Buy |
1,665
+125
| +8% | +$15.2K | 0.01% | 360 |
|
|
2017
Q1 | $187K | Sell |
1,540
-16
| -1% | -$1.94K | 0.01% | 378 |
|
|
2016
Q4 | $190K | Buy |
1,556
+6
| +0.4% | +$733 | 0.01% | 382 |
|
|
2016
Q3 | $190K | Sell |
1,550
-185
| -11% | -$22.7K | 0.01% | 385 |
|
|
2016
Q2 | $203K | Buy |
1,735
+83
| +5% | +$9.71K | 0.01% | 358 |
|
|
2016
Q1 | $230K | Buy |
1,652
+95
| +6% | +$13.2K | 0.01% | 330 |
|
|
2015
Q4 | $297K | Buy |
1,557
+32
| +2% | +$6.1K | 0.01% | 315 |
|
|
2015
Q3 | $240K | Hold |
1,525
| – | – | 0.01% | 358 |
|
|
2015
Q2 | $274K | Buy |
1,525
+410
| +37% | +$73.7K | 0.01% | 372 |
|
|
2015
Q1 | $194K | Buy |
1,115
+195
| +21% | +$33.9K | 0.01% | 419 |
|
|
2014
Q4 | $171K | Sell |
920
-280
| -23% | -$52K | 0.01% | 388 |
|
|
2014
Q3 | $199K | Hold |
1,200
| – | – | 0.01% | 397 |
|
|
2014
Q2 | $189K | Buy |
1,200
+100
| +9% | +$15.8K | 0.01% | 397 |
|
|
2014
Q1 | $168K | Sell |
1,100
-5,800
| -84% | -$886K | 0.01% | 402 |
|
|
2013
Q4 | $917K | Buy |
6,900
+1,041
| +18% | +$138K | 0.05% | 202 |
|
|
2013
Q3 | $681K | Sell |
5,859
-10,491
| -64% | -$1.22M | 0.04% | 241 |
|
|
2013
Q2 | $1.51M | Buy |
+16,350
| New | +$1.51M | 0.09% | 177 |
|